Parallax Health Sciences Inc (PRLX) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Parallax Health Sciences Inc   (PRLX)

Parallax Health Sciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Parallax Health Sciences Inc in the fourth quarter 2019?
Due to the lack of equity, it was not possible to calculate Parallax Health Sciences Inc 's return on equity (ROE) in its fourth quarter 2019

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -13 -9 19 18 15
Return On Equity (TTM) - - - - -
PRLX's Total Ranking # # # # #
Equity (TTM) in Millions -10 -5 -6 -6 -6
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to PRLX Management Effectiveness >> PRLX's 5 Years Annual ROE >> Compare PRLX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





PRLX Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions -10 -6 -27 -18 -5
Y / Y Equity Change - - - - -
Net Income in Millions -13 15 -14 -13 -4
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to PRLX Management Effectiveness >> PRLX's 5 Years Annual ROE >> Compare PRLX ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PRLX's' Return on Equity at Yahoo Finance
PRLX's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PRLX's Competitors
Subscribers only: Roe for Parallax Health Sciences Inc 's Suppliers
Subscribers only: Return On Equity for PRLX's Customers




Companies with similar Return On Equity at Dec 31 2019, within Healthcare Sector ROE
Tuhura Biosciences Inc   497.74 %
Lexicon Pharmaceuticals Inc   303.98 %
Coherus Oncology inc   302.63 %
Xbiotech Inc   288.62 %
Eli Lilly And Company  287.25 %
Idexx Laboratories Inc  283.32 %
Collplant Biotechnologies Ltd  273.09 %
Quoin Pharmaceuticals Ltd   232.48 %
Aveo Pharmaceuticals Inc   225.40 %
Check Cap Ltd  221.94 %
Morphic Holding inc   212.35 %
Orgenesis Inc   183.75 %
Waters Corporation  166.44 %
Semler Scientific inc   152.53 %
Integrated Biopharma Inc  117.48 %
Nrc Health  117.23 %
Mettler toledo International Inc   116.60 %
Tenax Therapeutics Inc   114.72 %
Surgalign Holdings Inc   113.88 %
Altamira Therapeutics Ltd   107.01 %
Jounce Therapeutics inc   82.61 %
Biomx Inc  81.49 %
Molecular Templates Inc   81.33 %
Amgen Inc   74.29 %
Innoviva Inc   71.23 %
Castle Biosciences Inc   69.30 %
Novo Nordisk A  67.49 %
Ligand Pharmaceuticals Incorporated  67.32 %
Zynex inc   61.51 %
Progyny Inc   60.87 %

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.